Janesko, B
Understanding these factors helps you take an active role in maximizing and extending your results
A meta-analysis published in 2020 shows that L-carnitine supplementation for patients with non-alcoholic fatty liver disease demonstrates a reduction in AST, ALT, TG levels, and HOMA-IR [15]
It is uniquely formulated with enhanced absorption technology to ensure maximum bioavailability, making it a superior choice in the marketplace
Your results include reference ranges based on healthy populations
Composition: Aqua, Butylene Glycol, Glycerin, Japanese Koji Rice Ferment Filtrate, Caprylyl/Capryl Glucoside, Polyglyceryl-10 Isostearate, Sodium Dilauramidoglutamide Lysine, Silica, Sodium Acrylates Crosspolymer-2, Niacinamide, Glycolic Acid, Glutathione, Azadirachta Indica Leaf Extract, Glycyrrhiza Glabra Root Extrac